- Sections
- C - Chimie; métallurgie
- C12N - Micro-organismes ou enzymes; compositions les contenant; culture ou conservation de micro-organismes; techniques de mutation ou de génétique; milieux de culture
- C12N 15/85 - Vecteurs ou systèmes d'expression spécialement adaptés aux hôtes eucaryotes pour cellules animales
Détention brevets de la classe C12N 15/85
Brevets de cette classe: 9716
Historique des publications depuis 10 ans
|
519
|
583
|
630
|
757
|
1008
|
1003
|
865
|
983
|
939
|
325
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 3650 |
349 |
| The Regents of the University of California | 18943 |
197 |
| The Trustees of the University of Pennsylvania | 4122 |
145 |
| Massachusetts Institute of Technology | 9795 |
136 |
| President and Fellows of Harvard College | 5792 |
123 |
| Sangamo Therapeutics, Inc. | 437 |
89 |
| The Broad Institute, Inc. | 1584 |
84 |
| The Board of Trustees of the Leland Stanford Junior University | 6054 |
79 |
| Kymab Limited | 229 |
63 |
| The Johns Hopkins University | 5377 |
56 |
| The General Hospital Corporation | 4517 |
55 |
| University of Massachusetts | 2130 |
55 |
| Biocytogen Pharmaceuticals (Beijing) Co., Ltd | 133 |
53 |
| Duke University | 2872 |
51 |
| Novartis AG | 11238 |
50 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2737 |
47 |
| Board of Regents, The University of Texas System | 5370 |
44 |
| Modernatx, Inc. | 1181 |
43 |
| F. Hoffmann-La Roche AG | 7958 |
41 |
| Genentech, Inc. | 3742 |
40 |
| Autres propriétaires | 7916 |